DWTC, Za'abeel 2 (French pavilion - Booth Z2H53)

 

 

United Arab Emirates- June 16, 2021:   The 2021 edition of Arab Health will take place in Dubai from 21 to 24 June. This edition’s line-up will include an innovative company working in the field of medical devices and e-health: Sublimed. The show will be an opportunity for the start-up to unveil its drug-free chronic pain management device: actiTENS

 

Sublimed, an innovative start-up

 

Did you know that 20% of the world's population suffers from chronic pain?  Founded in 2015, Sublimed understood the main challenges and innovates developing a non-drug and non-invasive treatment based on transcutaneous electrical neurostimulation (TENS) therapy. In 2018, Sublimed launched its portable and miniaturised neurostimulator, actiTENS. A true breakthrough for patients who do not have many alternatives other than medication and especially opioids, which were responsible in 2020 of more than 80,000 deaths only in the United States.

 

From chronic pain to active life

 

actiTENS is a compact and connected neurostimulator based on transcutaneous electrical neurostimulation therapy. actiTENS directly targets patients’ pain through two mechanisms, the first actively interfering with pain signals’ neural transmission, and the second stimulating the production of endorphins, for long-lasting pain relief effects. The device can be controlled directly from a smartphone, be used unnoticeably and accompanies patients in their daily activities. Its small size, light weight and flexible architecture enable easy placement on different parts of the body, in accordance with patients’ needs and doctors’ recommendations. actiTENS has now more than 10,000 active users in France and is beginning its international expansion to provide chronic pain patients around the world with a clinically validated drug-free treatment.

 

A clinically proven revolution in osteoarthritis knee pain treatment 

 

Sublimed recently completed a clinical study on 110 patients with knee osteoarthritis. The study findings demonstrate the superiority of actiTENS over weak opioids (tramadol, acetaminophen-opium powder, etc.) in managing osteoarthritis knee pain. After a pain reduction by more than 2 points on a scale of 0 to 10, patients with severe pain were able to reach a state of mild pain thanks to actiTENS after only 3 months. actiTENS is thus a more effective drug-free therapeutic alternative to opioids, which are a source of addiction, inconvenience and daily danger for patients, especially when used for extended periods of time.

 

Come and meet Sublimed during Arab Health 2021 at the Za'abeel 2 - French pavilion (Booth Z2H53) and find out all you need to know about this drug-free medical device for chronic pain management.